Rivaroxaban versus vitamin K antagonist treatment on the progression of coronary calcification: the IRIVASC-trial
Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Vincent Brandenburg, Sebastian Reinartz(Universitätsklinikum Aachen), Klaus K. Witte(University of Leeds), Timm Dirrichs, Alexander Schuh
Cited by 2
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
|Nature Biotechnology|2024|265
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS
|Deutsches Ärzteblatt international|2020|258
The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing
|Molecular Cancer Research|2010|227